GI innovation announced on the 10th that it has signed an MOU with Merck for the manufacture and development of new biopharmaceuticals.

This is the first time Merck, which has maintained cooperative relationships with CDMO (Consignment Production and Development) companies such as Samsung Biologics and Binex, has cooperated with Biotech in Korea to support the manufacture and development of new biopharmaceuticals.

Merck is known to have highly appreciated GI innovation's know-how in developing CHO-produced cell lines and various pipelines.

Hong Joon-ho, CEO of GI innovation, Cho Young-kyu, Oh Young-min, and Kim Yong-seok, general manager of Merck Life Science process solut